ED50 < 50 ng/mL, measured by a cell proliferation assay using MCF-7 cells, corresponding to a specific activity of > 2x 10^4 units/mg. AA 25-176, expressed with an N-terminal Met.
IL19
Origine: Humain
Hôte: Escherichia coli (E. coli)
Recombinant
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstituted in 50 mM acetic acid at 50 μg/mL.
Buffer
Lyophilized after extensive dialysis against 50 mM acetic acid.
Stock
-80 °C
Stockage commentaire
Lyophilized recombinant mouse Interleukin-19 (rmIL-19) remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, rmIL-19 remains stable up to 2 weeks at 4 °C or up to 3 months at -20 °C.
Interleukin-19 (IL-19) is a cytokine belonging to the interleukin family. Structurally, IL-19 is grouped into the IL-10 sub-family, which also includes IL-20, IL-22, IL-24, and IL-26. In contrast to IL-10, which exists as a homodimer, IL-19 is stable and active as a monomer in vivo. IL-19 functions through the receptor complex composed of IL-20 Receptor alpha and IL-20 Receptor beta, which is also utilized by IL-20 and IL-24. IL-19 is produced by active monocytes and stimulated synergistically by IL-17 and IL-13. The functions of IL-19 are to promote the development and function of Th2 cells and to enhance the production of Th2 cytokines. IL-19 is implicated in aging, vascular disease, Type I diabetes, and rheumatoid arthritis. Recombinant mouse Interleukin-19 (rmIL-19) produced in E. coli is a single non-glycosylated polypeptide chain containing of153 amino acids. A fully biologically active molecule, rmIL-19 has a molecular mass of 17.7 kDa analyzed by non-reducing SDS-PAGE. Synonyms: Melanoma differentiation association like protein, MDA1, NG.1, ZMDA1, IL-10C, IL-19